A Twitter-based survey on marijuana concentrate use

Drug and Alcohol Dependence

Volumn 187, Issue , 2018, Pages 155-159

  Daniulaityte, Raminta ^a,b   Zatreh, Mussa Y ^a   Lamy, Francois R ^c   Nahhas, Ramzi W ^a   Martins, Silvia S ^d   Sheth, Amit ^b   Carlson, Robert G ^a,b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b Wright State University   (United States)

^c MAHIDOL UNIVERSITY   (Thailand)

^d Department of Medicine   (United States)

Author keywords

Cannabis; Cannabis legalization; Marijuana concentrates; Social media; Twitter; Web survey

Indexed keywords

ADULT; ARTICLE; CANNABIS USE; CORRELATIONAL STUDY; FEMALE; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; RECREATION; RESIDENTIAL AREA; RISK FACTOR; SOCIAL STATUS; WEB BROWSER; CANNABIS SMOKING; EPIDEMIOLOGY; INTERNET; QUESTIONNAIRE; SOCIAL MEDIA; TRENDS; UNITED STATES; YOUNG ADULT;

CANNABIS; MEDICAL CANNABIS;

ADULT; CANNABIS; FEMALE; HUMANS; INTERNET; MALE; MARIJUANA SMOKING; MARIJUANA USE; MEDICAL MARIJUANA; SOCIAL MEDIA; SURVEYS AND QUESTIONNAIRES; UNITED STATES; YOUNG ADULT;

EID: 85045392252     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2018.02.033     Document Type: Article

References (38)

1. Barratt, M.J., Lenton, S., Representativeness of online purposive sampling with Australian cannabis cultivators. Int. J. Drug Policy 26 (2015), 323–326.
2. Borodovsky, J.T., Crosier, B.S., Lee, D.C., Sargent, J.D., Budney, A.J., Smoking, vaping, eating: is legalization impacting the way people use cannabis?. Int. J. Drug Policy 36 (2016), 141–147.
3. Carlini, B.H., Garrett, S.B., Harwick, R.M., Beyond joints and brownies: marijuana concentrates in the legal landscape of WA State. Int. J. Drug Policy 42 (2017), 26–29.
4. Cavazos-Rehg, P.A., Krauss, M., Fisher, S.L., Salyer, P., Grucza, R.A., Bierut, L.J., Twitter chatter about marijuana. J. Adolesc. Health 56 (2015), 139–145.
5. Cavazos-Rehg, P.A., Krauss, M.J., Sowles, S., Connolly, S., Rosas, C., Bharadwaj, M., Bierut, L.J., A content analysis of depression-related Tweets. Comput. Human Behav. 54 (2016), 351–357.
6. Cavazos-Rehg, P.A., Sowles, S.J., Krauss, M.J., Agbonavbare, V., Grucza, R., Bierut, L., A content analysis of tweets about high-potency marijuana. Drug Alcohol Depend. 166 (2016), 100–108.
7. U. S. Census Bureau, State and County QuickFacts: 2017 Population Estimates. 2017 http://www.census.gov/.accessed on 02/19/2018.
8. Chan, G.C.K., Hall, W., Freeman, T.P., Ferris, J., Kelly, A.B., Winstock, A., User characteristics and effect profile of Butane Hash Oil: an extremely high-potency cannabis concentrate. Drug Alcohol Depend. 178 (2017), 32–38.
9. Chapman, S.A., Spetz, J., Lin, J., Chan, K., Schmidt, L.A., Capturing heterogeneity in medical marijuana policies: a taxonomy of regulatory regimes across the United States. Subst. Use Misuse 51 (2016), 1174–1184.
10. Daniulaityte, R., Nahhas, R.W., Wijeratne, S., Carlson, R.G., Lamy, F.R., Martins, S.S., Boyer, E.W., Smith, G.A., Sheth, A., Time for dabs: analyzing Twitter data on marijuana concentrates across the U.S. Drug Alcohol Depend. 155 (2015), 307–311.
11. Daniulaityte, R., Lamy, F.R., Barratt, M., Nahhas, R.W., Martins, S.S., Boyer, E.W., Sheth, A., Carlson, R.G., Characterizing marijuana concentrate users: a web-based survey. Drug Alcohol Depend. 178 (2017), 399–407.
12. Daniulaityte, R., Lamy, F.R., Smith, G.A., Nahhas, R.W., Carlson, R.G., Thirunarayan, K., Martins, S.S., Boyer, E.W., Sheth, A., Retweet to Pass the Blunt: analyzing geographic and content features of cannabis-related tweeting across the United States. J. Stud. Alcohol Drugs 78 (2017), 910–915.
13. ElSohly, M.A., Mehmedic, Z., Foster, S., Gon, C., Chandra, S., Church, J.C., Changes in cannabis potency over the last 2 decades (1995–2014): analysis of current data in the United States. Biol. Psychiatry 79 (2016), 613–619.
14. Guillory, J., Kim, A., Murphy, J., Bradfield, B., Nonnemaker, J., Hsieh, Y., Comparing Twitter and online panels for survey recruitment of e-cigarette users and smokers. J. Med. Internet Res., 18, 2016, e288.
15. Hall, W., Degenhardt, L., Adverse health effects of non-medical cannabis use. Lancet 374 (2009), 1383–1391.
16. Hommel, G., A comparison of two modified Bonferroni procedures. Biometrika 75 (1988), 383–386.
17. IBM-Corporation, IBM SPSS Statistic for Mac. 2016, IBM Corp., Armonk, NY.
18. Keller, C.J., Chen, E.C., Brodsky, K., Yoon, J.H., A case of butane hash oil (marijuana wax)-induced psychosis. Subst. Abuse 37 (2016), 384–386.
19. Kleiman, M.A.R., Legal Commercial Cannabis Sales in Colorado and Washington: What can We Learn. 2015, Brookings Institution, Washington, DC.
20. Lamy, F.R., Daniulaityte, R., Zatreh, M., Nahhas, R.W., Sheth, A., Martins, S.S., Boyer, E.W., Carlson, R.G., You got to love rosin Solventless dabs, pure, clean, natural medicine. Drug Alcohol Depend. 183 (2017), 248–252.
21. Lankenau, S.E., Fedorova, E.V., Reed, M., Schrager, S.M., Iverson, E., Wong, C.F., Marijuana practices and patterns of use among young adult medical marijuana patients and non-patient marijuana users. Drug Alcohol Depend. 170 (2017), 181–188.
22. Lee, D.C., Crosier, B.S., Borodovsky, J.T., Sargent, J.D., Budney, A.J., Online survey characterizing vaporizer use among cannabis users. Drug Alcohol Depend. 159 (2016), 227–233.
23. Loflin, M., Earleywine, M., A new method of cannabis ingestion: the dangers of dabs?. Addict. Behav. 39 (2014), 1430–1433.
24. Lord, S., Brevard, J., Budman, S., Connecting to young adults: an online social network survey of beliefs and attitudes associated with prescription opioid misuse among college students. Subst. Use Misuse 46 (2011), 66–76.
25. Meier, M.H., Associations between butane hash oil use and cannabis-related problems. Drug Alcohol Depend. 179 (2017), 25–31.
26. Monte, A.A., Zane, R.D., Heard, K.J., The implications of marijuana legalization in Colorado. JAMA 313 (2015), 241–242.
27. Pacula, R.L., Powell, D., Heaton, P., Sevigny, E.L., Assessing the effects of medical marijuana laws on marijuana use: the devil is in the details. J. Policy Anal. Management 34 (2015), 7–31.
28. Pacula, R.L., Jacobson, M., Maksabedian, E.J., In the weeds: a baseline view of cannabis use among legalizing states and their neighbours. Addiction 111 (2016), 973–980.
29. Pierre, J.M., Gandal, M., Son, M., Cannabis-induced psychosis associated with high potency “wax dabs”. Schizophr. Res. 172 (2016), 211–212.
30. Qualtrics, Qualtrics Software. 2016 Provo Utah.
31. Raber, J.C., Elzinga, S., Kaplan, C., Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing. J. Toxicol. Sci. 40 (2015), 797–803.
32. Ramo, D.E., Prochaska, J.J., Broad reach and targeted recruitment using Facebook for an online survey of young adult substance use. J. Med. Internet Res., 14, 2012, e28.
33. Russo, E.B., Current therapeutic cannabis controversies and clinical trial design issues. Front. Pharmacol., 7, 2016, 309.
34. SAS Institute Inc, SAS Version 9.4. 2012, SAS Institute Inc., Cary, NC.
35. Stogner, J.M., Miller, B.L., The dabbing dilemma: a call for research on butane hash oil and other alternate forms of cannabis use. Subst. Abuse 36 (2015), 393–395.
36. Walsh, Z., Callaway, R., Belle-Isle, L., Capler, R., Kay, R., Lucas, P., Holtzman, S., Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use. Int. J. Drug Policy 24 (2013), 511–516.
37. Williams, A.R., Olfson, M., Kim, J.H., Martins, S.S., Kleber, H.D., Older, less regulated medical marijuana programs have much greater enrollment rates than newer ‘medicalized’ programs. Health Aff. 35 (2016), 480–488.
38. Zhang, Z., Zheng, X., Zeng, D.D., Leischow, S.J., Tracking dabbing using search query surveillance: a case study in the United States. J. Med. Internet Res., 18, 2016, e252.